Online citations, reference lists, and bibliographies.
← Back to Search

Genes That Mediate Breast Cancer Metastasis To Lung

A. Minn, G. Gupta, P. Siegel, P. Bos, Weiping Shu, D. Giri, A. Viale, A. Olshen, W. Gerald, J. Massagué
Published 2005 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
By means of in vivo selection, transcriptomic analysis, functional verification and clinical validation, here we identify a set of genes that marks and mediates breast cancer metastasis to the lungs. Some of these genes serve dual functions, providing growth advantages both in the primary tumour and in the lung microenvironment. Others contribute to aggressive growth selectively in the lung. Many encode extracellular proteins and are of previously unknown relevance to cancer metastasis.
This paper references
10.1002/jcb.20091
SPARC and tumor growth: Where the seed meets the soil?
P. E. Framson (2004)
10.1038/35021093
Molecular portraits of human breast tumours
C. Perou (2000)
10.1038/ng1060
A molecular signature of metastasis in primary solid tumors
S. Ramaswamy (2003)
10.1023/A:1025957025773
Helix-Loop-Helix Proteins in Mammary Gland Development and Breast Cancer
P. Desprez (2004)
10.1002/jcb.240350804
Tumor progression and metastasis
R. Kath (1990)
10.1084/jem.20020906
Enhanced Interleukin (IL)-13 Responses in Mice Lacking IL-13 Receptor α 2
N. Wood (2003)
10.1172/JCI22320
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.
A. Minn (2005)
10.1053/J.SEMINONCOL.2004.03.042
The role of COX-2 inhibition in breast cancer treatment and prevention.
B. Arun (2004)
10.1016/j.cell.2004.06.006
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
J. Yang (2004)
10.1038/35052073
Untangling the ErbB signalling network
Y. Yarden (2001)
10.1186/bcr65
Metalloproteinases: role in breast carcinogenesis, invasion and metastasis
M. Duffy (2000)
10.1038/nm733
Gene-expression profiles predict survival of patients with lung adenocarcinoma
D. Beer (2002)
10.1038/35020106
Genomic analysis of metastasis reveals an essential role for RhoC
E. Clark (2000)
10.1038/nrc865
Metastasis: Dissemination and growth of cancer cells in metastatic sites
A. Chambers (2002)
10.1038/nrc1098
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited
I. Fidler (2003)
10.1038/nrc1388
Cancer and the chemokine network
F. Balkwill (2004)
10.1007/s00259-003-1441-5
A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging
V. Ponomarev (2003)
10.1158/1078-0432.CCR-04-0183
Altered Expression of Metastasis-Associated and Regulatory Molecules in Effusions from Breast Cancer Patients
B. Davidson (2004)
10.1007/BF02616120
Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization
R. Cailleau (2007)
10.1038/sj.bjc.6601326
Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data
R. Simon (2003)
10.1074/jbc.273.17.10496
Epiregulin Is a Potent Pan-ErbB Ligand That Preferentially Activates Heterodimeric Receptor Complexes*
M. Shelly (1998)
10.1038/415530a
Gene expression profiling predicts clinical outcome of breast cancer
L. J. Veer (2002)
10.1200/JCO.2000.18.3.591
Clinical progression of breast cancer malignant behavior: what to expect and when to expect it.
R. Heimann (2000)
A progression puzzle.
R. Bernards (2002)
10.1023/A:1006308619659
Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis
E. Solomayer (2004)
Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumour progression
B Davidson (2004)
10.1038/nrc745
New functions for the matrix metalloproteinases in cancer progression
M. Egeblad (2002)
10.1016/S0092-8674(03)00468-9
Metastatic Potential Generic Predisposition of the Primary Tumor or Rare, Metastatic Variants—Or Both?
R. Hynes (2003)
10.1093/JNCI/DJH253
Probabilities of death from breast cancer and other causes among female breast cancer patients.
C. Schairer (2004)
10.1016/S0959-8049(02)00218-6
Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma.
D. O'hanlon (2002)
10.1158/0008-5472.CAN-03-2361
Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific Genes
S. Amatschek (2004)
Gene expression profiling predicts clinical outcome of breast cancer
van ’t Veer (2002)
10.1016/S1535-6108(03)00132-6
A multigenic program mediating breast cancer metastasis to bone.
Y. Kang (2003)
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
J. (2002)
10.1016/S0962-8924(03)00147-8
Id proteins in development, cell cycle and cancer.
M. Ruzinova (2003)



This paper is referenced by
10.1038/onc.2012.417
Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis
E. Louie (2013)
10.1158/0008-5472.CAN-10-2695
The novel metastasis promoter Merm1/Wbscr22 enhances tumor cell survival in the vasculature by suppressing Zac1/p53-dependent apoptosis.
Y. Nakazawa (2011)
10.1186/1471-2164-7-166
Comparative analysis and integrative classification of NCI60 cell lines and primary tumors using gene expression profiling data
Huixia Wang (2006)
10.1002/jor.22898
Expression of angiopoietin‐like protein 4 at the fracture site: Regulation by hypoxia and osteoblastic differentiation
Sabrina S Wilson (2015)
10.1002/ijc.27324
The metastatic microenvironment: Brain‐residing melanoma metastasis and dormant micrometastasis
Sivan Izraely (2012)
10.4103/2228-7477.114382
Hybrid Method for Prediction of Metastasis in Breast Cancer Patients Using Gene Expression Signals
A. Dehnavi (2013)
10.1002/path.2801
Tracing the origins of metastasis
D. Nguyen (2011)
10.1038/bjc.2014.298
Elevated expression of myosin X in tumours contributes to breast cancer aggressiveness and metastasis
R. Cao (2014)
10.1111/gtc.12743
Establishment and characterization of highly osteolytic luminal breast cancer cell lines by intracaudal arterial injection
Y. Han (2019)
10.5772/19314
Cancer Stem Cells: The Role of the Environment and Methods to Identify Them
G. Pirozzi (2011)
10.3390/cancers11040442
Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy
Meital Ben-David-Naim (2019)
Pathology and Biological Markers of Invasive Breast Cancer
Rodrigo Gonçalves (2014)
Osteoactivin Promotes Breast Cancer Metastasis to Bone April
A. N. Rose (2007)
10.3779/j.issn.1009-3419.2014.03.20
[Screening and establishment of human lung cancer cell lines with organ-specific metastasis potential].
Q. Zhou (2014)
10.1016/J.CBPA.2006.06.028
Molecular imaging strategies for drug discovery and development.
S. Gross (2006)
10.1186/1471-2407-9-258
Role of KCNMA1 gene in breast cancer invasion and metastasis to brain
D. Khaitan (2008)
10.1089/ADT.2006.4.483
Exploring the molecular basis of tumor metastasis by microarray analysis.
J. Yang (2006)
10.1007/s12013-007-0036-3
Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle
M. K. Singh (2007)
10.5451/UNIBAS-005213494
Investigating the contribution of FGF receptors in breast tumorigenesis using models of mammary cancer
J. Dey (2010)
10.1007/978-1-4419-1160-5_6
Gene Expression Arrays in Pancreatic Cancer Drug Discovery Research
Charles Gawad (2010)
10.1200/JCO.2009.22.8775
Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.
J. Staaf (2010)
10.1016/j.biomaterials.2012.10.018
A specific peptide ligand-modified lipid nanoparticle carrier for the inhibition of tumor metastasis growth.
Z. Wang (2013)
10.1016/j.ccell.2016.02.013
PITPNC1 Recruits RAB1B to the Golgi Network to Drive Malignant Secretion.
Nils Halberg (2016)
Human epidermal growth factor receptor-2-positive breast cancer : does estrogen receptor status de fi ne two distinct subtypes ?
M. Carayol (2013)
10.1158/0008-5472.CAN-14-1809
Bioengineered implantable scaffolds as a tool to study stromal-derived factors in metastatic cancer models.
Francesca Bersani (2014)
Microbial and epigenetic factors in the pathogenesis of nasopharyngeal carcinoma
Xiaoying Zhou (2015)
10.1007/s10549-008-9925-4
Integrated gene expression profile predicts prognosis of breast cancer patients
Lian-fang Li (2008)
10.1158/0008-5472.CAN-08-4573
The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
Bérengère Fayard (2009)
10.3389/fonc.2018.00174
Sialic Acid Metabolism: A Key Player in Breast Cancer Metastasis Revealed by Metabolomics
S. T. Teoh (2018)
10.1186/s13058-015-0621-0
Human breast cancer cells educate macrophages toward the M2 activation status
S. Sousa (2015)
10.18632/oncotarget.7828
Long non-coding RNAs as prognostic markers in human breast cancer
Hairong Liu (2016)
Award Number: W81XWH-06-1-0073 TITLE: Do Deregulated Cas Proteins Induce Genomic Instability in Early-Stage Ovarian Cancer
Erica A. Golemis (2006)
See more
Semantic Scholar Logo Some data provided by SemanticScholar